Concurrent Investment Advisors, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 2001015 Tampa, FL

Position in VRTX

as of Mar 31, 2026 · filed Apr 21, 2026 Compact

Position Value

$4,234,984

-$178,021 QoQ

Shares Held

9,484

-2.6% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Concurrent Investment Advisors, LLC holds $31,084,354 across 38 Biotechnology names. VRTX ranks #2 (13.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	347,786	$11,316,956
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	9,484	$4,234,984
3	CRSP	CRISPR Therapeutics AG	62,423	$2,969,461
4	EXEL	Exelixis, Inc.	36,987	$1,586,372
5	REGN	Regeneron Pharmaceuticals, Inc.	1,968	$1,520,555
6	ROIV	Roivant Sciences Ltd.	43,787	$1,212,899
7	INSM	INSMED Inc	5,141	$840,656
8	ACAD	Acadia Pharmaceuticals Inc	29,405	$654,555

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,234,984	9,484	-2.6%	Shares	Sole	2026-04-21
2025-12-31	$4,413,005	9,734	+242.9%	Shares	Sole	2026-01-29
2025-09-30	$1,111,865	2,839	-9.0%	Shares	Sole	2025-10-27
2025-06-30	$1,389,024	3,120	-2.9%	Shares	Sole	2025-07-25
2025-03-31	$1,557,726	3,213	+55.1%	Shares	Sole	2025-04-29
2024-12-31	$834,394	2,072	0.0%	Shares	Sole	2025-02-03
2024-09-30	$963,645	2,072	+35.3%	Shares	Sole	2024-10-30
2024-06-30	$717,610	1,531	+19.0%	Shares	Sole	2024-07-30
2024-03-31	$537,978	1,287	+93.2%	Shares	Sole	2024-05-07
2023-12-31	$270,988	666	—	Shares	Sole	2024-04-15
No filing history on record for this holder in this stock.